Ampersand invests in Magritek

Ampersand Capital Partners has made a minority investment in New Zealand-based Magritek, a provider of benchtop and portable NMR instruments for life sciences and other industries.

18 March 2021•2 mins read
private equity deals, PE Hub
LinkedInXEmail
LinkedInXEmail

Related articles